Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolution of SARS-CoV-2 during the first year of the COVID-19 pandemic in Northwestern Argentina.
Zambrana Montaño R, Culasso ACA, Fernández F, Marquez N, Debat H, Salmerón M, Zamora AM, Ruíz de Huidobro G, Costas D, Alabarse G, Charre MA, Fridman AD, Mamani C, Vaca F, Maza Diaz C, Raskovsky V, Lavaque E, Lesser V, Cajal P, Agüero F, Calvente C, Torres C, Viegas M. Zambrana Montaño R, et al. Virus Res. 2023 Jan 2;323:198936. doi: 10.1016/j.virusres.2022.198936. Epub 2022 Sep 28. Virus Res. 2023. PMID: 36181975 Free PMC article.
COVID-19 and vaccine hesitancy: A longitudinal study.
Fridman A, Gershon R, Gneezy A. Fridman A, et al. PLoS One. 2021 Apr 16;16(4):e0250123. doi: 10.1371/journal.pone.0250123. eCollection 2021. PLoS One. 2021. PMID: 33861765 Free PMC article.
Increased generosity under COVID-19 threat.
Fridman A, Gershon R, Gneezy A. Fridman A, et al. Sci Rep. 2022 Mar 31;12(1):4886. doi: 10.1038/s41598-022-08748-2. Sci Rep. 2022. PMID: 35361800 Free PMC article.
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial.
Strizki JM, Grobler JA, Murgolo N, Fridman A, Johnson MG, Du J, Carmelitano P, Brown ML, Paschke A, De Anda C. Strizki JM, et al. Among authors: fridman a. Infect Dis Ther. 2024 May;13(5):1159-1160. doi: 10.1007/s40121-024-00947-w. Infect Dis Ther. 2024. PMID: 38662333 Free PMC article. No abstract available.
Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface.
Xiao X, Wen Z, Chen Q, Shipman JM, Kostas J, Reid JC, Warren C, Tang A, Luo B, O'Donnell G, Fridman A, Chen Z, Vora KA, Zhang L, Su H-P, Eddins MJ. Xiao X, et al. Among authors: fridman a. J Virol. 2023 Dec 21;97(12):e0105223. doi: 10.1128/jvi.01052-23. Epub 2023 Nov 30. J Virol. 2023. PMID: 38032197 Free PMC article.
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants.
Hollingsworth SA, Noland CL, Vroom K, Saha A, Sam M, Gao Q, Zhou H, Grandy DU, Singh S, Wen Z, Warren C, Ma XS, Malashock D, Galli J, Go G, Eddins M, Mayhood T, Sathiyamoorthy K, Fridman A, Raoufi F, Gomez-Llorente Y, Patridge A, Tang Y, Chen SJ, Bailly M, Ji C, Kingsley LJ, Cheng AC, Geierstanger BH, Gorman DM, Zhang L, Pande K. Hollingsworth SA, et al. Among authors: fridman a. Sci Rep. 2023 Aug 22;13(1):13668. doi: 10.1038/s41598-023-40919-7. Sci Rep. 2023. PMID: 37608223 Free PMC article.
163 results